Acquisition by Control Empresarial De Capitales S.a. De C.v. of 387393 shares of ProKidney Corp at 0.7134 subject to Rule 16b-3

PROK Stock  USD 3.10  0.06  1.97%   
About 73 percent of all ProKidney Corp's institutional investors are curious in acquiring. The analysis of the overall investor sentiment regarding ProKidney Corp suggests that many traders are confidant. ProKidney Corp's investing sentiment shows overall attitude of investors towards ProKidney Corp.
Filed transaction by ProKidney Corp 10 Percent Owner, Other: Add'l Rep. Persons-see Ex.99-1. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
Acquisition of 387393 class a ordinary shares (as defined in exhibit 99.1 hereto) at 0.7134 of ProKidney Corp by Control Empresarial De Capitales S.a. De C.v. on 22nd of April 2025. This event was filed by ProKidney Corp with SEC on 2025-04-22. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

ProKidney Corp's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the ProKidney Corp's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

ProKidney Corp Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards ProKidney Corp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

ProKidney Corp Historical Investor Sentiment

Investor biases related to ProKidney Corp's public news can be used to forecast risks associated with an investment in ProKidney. The trend in average sentiment can be used to explain how an investor holding ProKidney can time the market purely based on public headlines and social activities around ProKidney Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
ProKidney Corp's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for ProKidney Corp and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average ProKidney Corp news discussions. The higher the estimate score, the more favorable the investor's outlook on ProKidney Corp.

ProKidney Corp Maximum Pain Price Across January 16th 2026 Option Contracts

ProKidney Corp's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of ProKidney Corp close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of ProKidney Corp's options.

ProKidney Corp Fundamental Analysis

We analyze ProKidney Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ProKidney Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ProKidney Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Outstanding

Shares Outstanding Comparative Analysis

ProKidney Corp is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

ProKidney Corp Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ProKidney Corp stock to make a market-neutral strategy. Peer analysis of ProKidney Corp could also be used in its relative valuation, which is a method of valuing ProKidney Corp by comparing valuation metrics with similar companies.

Peers

ProKidney Corp Related Equities

XNCRXencor   2.95   
0%
41.0%
TNGXTango Therapeutics   0.51   
0%
7.0%
MNMDMind Medicine   0.31   
0%
4.0%
PHATPhathom Pharmaceuticals   0.07   
1.0%
0%
ANABAnaptysBio   0.11   
1.0%
0%
PGENPrecigen   1.23   
17.0%
0%
KURAKura Oncology   2.38   
33.0%
0%
EYPTEyepoint Pharmaceuticals   4.24   
59.0%
0%
MRVIMaravai Lifesciences   4.95   
69.0%
0%
BCAXBicara Therapeutics   7.08   
100.0%
0%
When determining whether ProKidney Corp is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if ProKidney Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Prokidney Corp Stock. Highlighted below are key reports to facilitate an investment decision about Prokidney Corp Stock:
Check out ProKidney Corp Hype Analysis, ProKidney Corp Correlation and ProKidney Corp Performance.
For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProKidney Corp. If investors know ProKidney will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProKidney Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.56)
Revenue Per Share
0.004
Return On Assets
(0.25)
Return On Equity
(0.41)
The market value of ProKidney Corp is measured differently than its book value, which is the value of ProKidney that is recorded on the company's balance sheet. Investors also form their own opinion of ProKidney Corp's value that differs from its market value or its book value, called intrinsic value, which is ProKidney Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProKidney Corp's market value can be influenced by many factors that don't directly affect ProKidney Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProKidney Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if ProKidney Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProKidney Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.